Terns Pharmaceuticals (TERN) Competitors $3.93 -0.17 (-4.15%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TERN vs. BGM, AMPH, CALT, GPCR, AUPH, WVE, NAGE, MLYS, RCUS, and SYREShould you be buying Terns Pharmaceuticals stock or one of its competitors? The main competitors of Terns Pharmaceuticals include Qilian International Holding Group (BGM), Amphastar Pharmaceuticals (AMPH), Calliditas Therapeutics AB (publ) (CALT), Structure Therapeutics (GPCR), Aurinia Pharmaceuticals (AUPH), Wave Life Sciences (WVE), Niagen Bioscience (NAGE), Mineralys Therapeutics (MLYS), Arcus Biosciences (RCUS), and Spyre Therapeutics (SYRE). These companies are all part of the "pharmaceutical products" industry. Terns Pharmaceuticals vs. Its Competitors Qilian International Holding Group Amphastar Pharmaceuticals Calliditas Therapeutics AB (publ) Structure Therapeutics Aurinia Pharmaceuticals Wave Life Sciences Niagen Bioscience Mineralys Therapeutics Arcus Biosciences Spyre Therapeutics Qilian International Holding Group (NASDAQ:BGM) and Terns Pharmaceuticals (NASDAQ:TERN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk. Does the MarketBeat Community prefer BGM or TERN? Terns Pharmaceuticals received 44 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformQilian International Holding GroupN/AN/ATerns PharmaceuticalsOutperform Votes4460.27% Underperform Votes2939.73% Does the media favor BGM or TERN? In the previous week, Terns Pharmaceuticals had 2 more articles in the media than Qilian International Holding Group. MarketBeat recorded 3 mentions for Terns Pharmaceuticals and 1 mentions for Qilian International Holding Group. Qilian International Holding Group's average media sentiment score of 1.89 beat Terns Pharmaceuticals' score of 1.52 indicating that Qilian International Holding Group is being referred to more favorably in the media. Company Overall Sentiment Qilian International Holding Group Very Positive Terns Pharmaceuticals Very Positive Which has better earnings and valuation, BGM or TERN? Qilian International Holding Group has higher revenue and earnings than Terns Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQilian International Holding Group$25.10M60.47-$1.44MN/AN/ATerns PharmaceuticalsN/AN/A-$90.21M-$1.09-3.61 Do insiders and institutionals have more ownership in BGM or TERN? 98.3% of Terns Pharmaceuticals shares are held by institutional investors. 58.7% of Qilian International Holding Group shares are held by insiders. Comparatively, 1.5% of Terns Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts prefer BGM or TERN? Terns Pharmaceuticals has a consensus price target of $15.63, suggesting a potential upside of 297.58%. Given Terns Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Terns Pharmaceuticals is more favorable than Qilian International Holding Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Terns Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Is BGM or TERN more profitable? Qilian International Holding Group's return on equity of 0.00% beat Terns Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Qilian International Holding GroupN/A N/A N/A Terns Pharmaceuticals N/A -32.76%-31.33% Which has more volatility and risk, BGM or TERN? Qilian International Holding Group has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500. Comparatively, Terns Pharmaceuticals has a beta of -0.18, suggesting that its share price is 118% less volatile than the S&P 500. SummaryQilian International Holding Group beats Terns Pharmaceuticals on 7 of the 13 factors compared between the two stocks. Get Terns Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TERN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TERN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TERN vs. The Competition Export to ExcelMetricTerns PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$343.23M$6.92B$5.61B$8.62BDividend YieldN/A2.55%5.28%4.18%P/E Ratio-3.338.6727.1419.96Price / SalesN/A262.53411.83157.63Price / CashN/A65.8538.2534.64Price / Book0.956.597.064.69Net Income-$90.21M$143.75M$3.23B$248.14M7 Day Performance11.02%3.72%2.67%2.39%1 Month Performance30.13%11.01%8.82%6.05%1 Year Performance-46.82%3.87%31.44%13.60% Terns Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TERNTerns Pharmaceuticals4.1701 of 5 stars$3.93-4.1%$15.63+297.6%-44.1%$343.23MN/A-3.3340Positive NewsBGMQilian International Holding GroupN/A$13.20+0.9%N/AN/A$1.28B$25.10M0.00298Gap DownHigh Trading VolumeAMPHAmphastar Pharmaceuticals3.653 of 5 stars$26.62+2.4%$32.33+21.5%-36.7%$1.25B$730.66M8.871,620CALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180GPCRStructure Therapeutics2.4857 of 5 stars$20.51-2.9%$76.50+273.0%-54.6%$1.18BN/A-27.72136News CoveragePositive NewsAnalyst RevisionAUPHAurinia Pharmaceuticals3.3317 of 5 stars$8.14-0.6%$11.50+41.3%+45.8%$1.10B$247.30M-54.26300Positive NewsAnalyst RevisionWVEWave Life Sciences4.4435 of 5 stars$7.05-2.4%$21.17+200.2%+16.0%$1.09B$104.94M-6.35240News CoveragePositive NewsAnalyst ForecastAnalyst RevisionNAGENiagen Bioscience1.4834 of 5 stars$13.43+3.7%$18.00+34.0%N/A$1.06B$107.93M79.00120News CoverageAnalyst ForecastMLYSMineralys Therapeutics3.0546 of 5 stars$16.19+0.4%$38.00+134.7%+19.7%$1.06BN/A-4.4528Positive NewsAnalyst ForecastRCUSArcus Biosciences2.5509 of 5 stars$9.86-1.1%$24.13+144.7%-41.9%$1.04B$141M-3.13500Options VolumeAnalyst RevisionGap UpSYRESpyre Therapeutics2.4 of 5 stars$17.16+1.1%$53.40+211.2%-52.6%$1.03B$890K-2.3073Positive News Related Companies and Tools Related Companies Qilian International Holding Group Competitors Amphastar Pharmaceuticals Competitors Calliditas Therapeutics AB (publ) Competitors Structure Therapeutics Competitors Aurinia Pharmaceuticals Competitors Wave Life Sciences Competitors Niagen Bioscience Competitors Mineralys Therapeutics Competitors Arcus Biosciences Competitors Spyre Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TERN) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terns Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TERN Stock Free TERN Stock Alerts